or
Bookmark and Share
   
Document Number
US Patent 7012135
Issued Date
March 14, 2006
Link
Map
Abstract
There is disclosed antibody molecules containing at least one CDR derived from a mouse monoclonal antibody having specificity for human TNF.alpha.. There is also disclosed a CDR grafted antibody wherein at least one of the CDRs is a hybrid CDR. Further disclosed are DNA sequences encoding the chains of the antibody molecules, vectors, transformed host cells and uses of the antibody molecules in the treatment of diseases mediated by TNF.alpha..
Tags:
Description:
Amusing 0%
Clever 0%
Complex 0%
Efficient 0%
Historic 0%
Important 0%
Innovative 0%
Interesting 0%
Practical 0%
Simple 0%
Number of Claims:
3
Comments:
no comments yet
Owner
Published
March 14, 2006
Application Number
09/875,221
Filed
June 6, 2001
US Classification
530/388.23   424/179.1 424/181.1 530/324 530/387.3
Int'l Classification
C07K   16/24   (20060101)  
Examiner
Assistant Examiner
Attorney/Law Firm
Priority Data
Jun 06, 2000 [GB] 0013810
USPTO Field of Search
530/388.23   530/387.3   530/324   424/179.1   424/181.1  
Related Patents
7402662 - Antibody molecules specific to human tumor necrosis factor alpha - Owned by UCB Pharma S.A. (Brussels,BE)

There is disclosed antibody molecules containing at least one CDR derived from a mouse monoclonal antibody having specificity for human TNF.alpha.. There is also disclosed a CDR grafted antibody wherein at least one of the CDRs is a hybrid CDR. Further disclosed are DNA sequences encoding the chains of the antibody molecules, vectors, transformed host cells and uses of the antibody molecules in the treatment of diseases mediated by TNF.alpha..

Claims
Description
About| FAQs| Terms & Disclaimer| Link to Us| Contact Us